Eric Dierks, DMD, MD

 Eric Dierks, DMD, MD

Eric Dierks, DMD, MD

1. Thursday, April 12, 2012
9 am – 12 pm
Recommended for: Dentists, Hygienists, Assistants
ODA Course
3 CE Credits
Note: Sponsored, in part, by the ODA Access to Care Committee
2. Saturday, April 14, 2012
Recommended for: Dentists
OSOMS Course
Note: This presentation is part of the course "OSOMS Symposium: Part 2"



1. Dental Evaluation and Management of the Radiated Cancer Patient
(Presented with Nico de Wette, MD and Wallace McKenzie, DMD)


The dentist and hygienist will learn about the preventive protocols for the pre-radiation patient and protocols for management of mucositis and the long term preventive issues of the head and neck cancer patient. The dental team will also learn about the special attempts by the radiation oncologist to preserve and minimize the damage to the oral structures. In seeing some of the complications caused by cancer treatment the dental team will better understand their role in maintenance and prevention for their special patients. 


2. Odontogenic Keratocyst/Keratocystic Odontogenic Tumor—Update in Diagnosis and Treatment(Presented with Jim Kratochvil, DDS; Julie Ann Smith, DDS, MD; Jeffery Stewart, DDS, MS)

The reclassification of the Odontogenic Keratocyst (OKC) to the Keratocystic Odontogenic Tumor (KOT or KCOT) by the World Health Organization was done in part to reflect the aggressive nature of this lesion, but it was also based on new findings regarding the genetics of this lesion and its possible relationship to the function of the tumor suppressor gene, PTCH.  The high recurrence rate of the KCOT has necessitated aggressive treatment.  The spectrum of treatment previously offered to patients has included either aggressive resection or enucleation and curettage with either peripheral ostectomy, treatment with Carnoy’s solution, or cryotherapy.  In recent years, marsupialization has proven to be a useful tool in shrinking these lesions, allowing the patient to avoid a more aggressive surgery.  In the future, there may be a role for molecular based treatment.  This course will focus on the clinical, radiographic, and pathologic diagnosis of this disease and the latest in management strategies. 

At the conclusion of this course, the attendee will be able to describe the radiographic and clinical behavior of KCOT in the non-syndromic and syndromic patient, describe the pathologic findings in KCOT lesions, and be aware of the various treatment modalities, including their risks and general success rates. 


Dr. Dierks received both his DMD and his MD from the University of Louisville. His residency in oral and maxillofacial surgery was done at the Christiana Medical Center of Delaware, and his residency in ENT-Head & Neck Surgery was completed at the University of Texas Southwestern Medical Center at Dallas. He is one of only about a dozen American surgeons to be board-certified in both specialties. Dr. Dierks is an Affiliate Professor of OMFS at Oregon Health & Science University as well as the University of Washington and practices within the Head and Neck Surgical Associates in Portland, Oregon. He has directed a fellowship in head and neck oncologic surgery since 1992. .